 | • レポートコード：QFJ1-5628 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、124ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、血漿誘導体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アルブミン、ファクターVIII、ファクターIX、イムノグロブリン、ハイパーイムンググロブリン、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・血漿誘導体の市場動向 ・企業の競争状況、市場シェア ・血漿誘導体の種類別市場規模と予測2016-2027（アルブミン、ファクターVIII、ファクターIX、イムノグロブリン、ハイパーイムンググロブリン、その他） ・血漿誘導体の用途別市場規模と予測2016-2027（病院、診療所、その他） ・血漿誘導体の北米市場規模2016-2027（アメリカ、カナダ） ・血漿誘導体の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・血漿誘導体のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・血漿誘導体の中南米市場規模2016-2027（メキシコ、ブラジル） ・血漿誘導体の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Grifols、SK Plasma、Fusion Health Care、Biotest AG、Green Cross Corporation、Baxter International、LFB、Octapharma AG、CSL Limited、Takeda、China Biologic Products、Kedrion Biopharma、BDI Pharma、Bayer AG、Hualan Biological Engineering） ・結論 |
Blood plasma is the liquid component of blood constituting of water along with plasma components such as immunoglobulin, electrolytes, glucose, clotting factors, electrolytes, and hormones. It plays a crucial role in maintaining the electrolyte and osmotic balance while preventing infection and blood disorders in the body. Plasma derivatives are the concentrates of specific proteins, which require pooling of plasma from large number of donors. For instance, they require more than hundred plasma donations to produce sufficient immunoglobulin to treat an immune-deficient patient for one year. They are obtained by the process of fractionation where protein concentrates are separated and then clinically used.
The growth of the global blood plasma derivatives market is majorly driven by increase in prevalence of life-threatening disorders, especially hemophilia. Other factors boosting the market growth include rise in adoption of blood plasma derivatives products, upsurge in geriatric population across the world, and increase in awareness about blood & plasma donation. However, factors such as high cost of plasma derivative-based therapy and post-operative risks associated with plasma replacement therapy hamper the market growth. Conversely, the development of enhanced methods for preservation of plasma derivatives along with advanced procedures for fractionation and high potential in untapped markets in the emerging economies are expected to provide lucrative growth opportunities for the market.
Market Analysis and Insights: Global Blood Plasma Derivatives Market
The global Blood Plasma Derivatives market size is projected to reach US$ 47030 million by 2027, from US$ 30890 million in 2020, at a CAGR of 5.7% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Blood Plasma Derivatives market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Blood Plasma Derivatives market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Blood Plasma Derivatives market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Blood Plasma Derivatives market.
Global Blood Plasma Derivatives Scope and Market Size
Blood Plasma Derivatives market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Blood Plasma Derivatives market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Albumin
Factor VIII
Factor IX
Immunoglobulin
Hyperimmune Globulin
Others
Segment by Application
Hospitals
Clinics
Other End Users
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Grifols
SK Plasma
Fusion Health Care
Biotest AG
Green Cross Corporation
Baxter International
LFB
Octapharma AG
CSL Limited
Takeda
China Biologic Products
Kedrion Biopharma
BDI Pharma
Bayer AG
Hualan Biological Engineering
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blood Plasma Derivatives Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Albumin
1.2.3 Factor VIII
1.2.4 Factor IX
1.2.5 Immunoglobulin
1.2.6 Hyperimmune Globulin
1.2.7 Others
1.3 Market by Application
1.3.1 Global Blood Plasma Derivatives Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other End Users
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Blood Plasma Derivatives Market Perspective (2016-2027)
2.2 Blood Plasma Derivatives Growth Trends by Regions
2.2.1 Blood Plasma Derivatives Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Blood Plasma Derivatives Historic Market Share by Regions (2016-2021)
2.2.3 Blood Plasma Derivatives Forecasted Market Size by Regions (2022-2027)
2.3 Blood Plasma Derivatives Industry Dynamic
2.3.1 Blood Plasma Derivatives Market Trends
2.3.2 Blood Plasma Derivatives Market Drivers
2.3.3 Blood Plasma Derivatives Market Challenges
2.3.4 Blood Plasma Derivatives Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Blood Plasma Derivatives Players by Revenue
3.1.1 Global Top Blood Plasma Derivatives Players by Revenue (2016-2021)
3.1.2 Global Blood Plasma Derivatives Revenue Market Share by Players (2016-2021)
3.2 Global Blood Plasma Derivatives Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Blood Plasma Derivatives Revenue
3.4 Global Blood Plasma Derivatives Market Concentration Ratio
3.4.1 Global Blood Plasma Derivatives Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blood Plasma Derivatives Revenue in 2020
3.5 Blood Plasma Derivatives Key Players Head office and Area Served
3.6 Key Players Blood Plasma Derivatives Product Solution and Service
3.7 Date of Enter into Blood Plasma Derivatives Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Blood Plasma Derivatives Breakdown Data by Type
4.1 Global Blood Plasma Derivatives Historic Market Size by Type (2016-2021)
4.2 Global Blood Plasma Derivatives Forecasted Market Size by Type (2022-2027)
5 Blood Plasma Derivatives Breakdown Data by Application
5.1 Global Blood Plasma Derivatives Historic Market Size by Application (2016-2021)
5.2 Global Blood Plasma Derivatives Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Blood Plasma Derivatives Market Size (2016-2027)
6.2 North America Blood Plasma Derivatives Market Size by Type
6.2.1 North America Blood Plasma Derivatives Market Size by Type (2016-2021)
6.2.2 North America Blood Plasma Derivatives Market Size by Type (2022-2027)
6.2.3 North America Blood Plasma Derivatives Market Size by Type (2016-2027)
6.3 North America Blood Plasma Derivatives Market Size by Application
6.3.1 North America Blood Plasma Derivatives Market Size by Application (2016-2021)
6.3.2 North America Blood Plasma Derivatives Market Size by Application (2022-2027)
6.3.3 North America Blood Plasma Derivatives Market Size by Application (2016-2027)
6.4 North America Blood Plasma Derivatives Market Size by Country
6.4.1 North America Blood Plasma Derivatives Market Size by Country (2016-2021)
6.4.2 North America Blood Plasma Derivatives Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Blood Plasma Derivatives Market Size (2016-2027)
7.2 Europe Blood Plasma Derivatives Market Size by Type
7.2.1 Europe Blood Plasma Derivatives Market Size by Type (2016-2021)
7.2.2 Europe Blood Plasma Derivatives Market Size by Type (2022-2027)
7.2.3 Europe Blood Plasma Derivatives Market Size by Type (2016-2027)
7.3 Europe Blood Plasma Derivatives Market Size by Application
7.3.1 Europe Blood Plasma Derivatives Market Size by Application (2016-2021)
7.3.2 Europe Blood Plasma Derivatives Market Size by Application (2022-2027)
7.3.3 Europe Blood Plasma Derivatives Market Size by Application (2016-2027)
7.4 Europe Blood Plasma Derivatives Market Size by Country
7.4.1 Europe Blood Plasma Derivatives Market Size by Country (2016-2021)
7.4.2 Europe Blood Plasma Derivatives Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Blood Plasma Derivatives Market Size (2016-2027)
8.2 Asia-Pacific Blood Plasma Derivatives Market Size by Type
8.2.1 Asia-Pacific Blood Plasma Derivatives Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Blood Plasma Derivatives Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Blood Plasma Derivatives Market Size by Type (2016-2027)
8.3 Asia-Pacific Blood Plasma Derivatives Market Size by Application
8.3.1 Asia-Pacific Blood Plasma Derivatives Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Blood Plasma Derivatives Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Blood Plasma Derivatives Market Size by Application (2016-2027)
8.4 Asia-Pacific Blood Plasma Derivatives Market Size by Region
8.4.1 Asia-Pacific Blood Plasma Derivatives Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Blood Plasma Derivatives Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Blood Plasma Derivatives Market Size (2016-2027)
9.2 Latin America Blood Plasma Derivatives Market Size by Type
9.2.1 Latin America Blood Plasma Derivatives Market Size by Type (2016-2021)
9.2.2 Latin America Blood Plasma Derivatives Market Size by Type (2022-2027)
9.2.3 Latin America Blood Plasma Derivatives Market Size by Type (2016-2027)
9.3 Latin America Blood Plasma Derivatives Market Size by Application
9.3.1 Latin America Blood Plasma Derivatives Market Size by Application (2016-2021)
9.3.2 Latin America Blood Plasma Derivatives Market Size by Application (2022-2027)
9.3.3 Latin America Blood Plasma Derivatives Market Size by Application (2016-2027)
9.4 Latin America Blood Plasma Derivatives Market Size by Country
9.4.1 Latin America Blood Plasma Derivatives Market Size by Country (2016-2021)
9.4.2 Latin America Blood Plasma Derivatives Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Blood Plasma Derivatives Market Size (2016-2027)
10.2 Middle East & Africa Blood Plasma Derivatives Market Size by Type
10.2.1 Middle East & Africa Blood Plasma Derivatives Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Blood Plasma Derivatives Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Blood Plasma Derivatives Market Size by Type (2016-2027)
10.3 Middle East & Africa Blood Plasma Derivatives Market Size by Application
10.3.1 Middle East & Africa Blood Plasma Derivatives Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Blood Plasma Derivatives Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Blood Plasma Derivatives Market Size by Application (2016-2027)
10.4 Middle East & Africa Blood Plasma Derivatives Market Size by Country
10.4.1 Middle East & Africa Blood Plasma Derivatives Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Blood Plasma Derivatives Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Grifols
11.1.1 Grifols Company Details
11.1.2 Grifols Business Overview
11.1.3 Grifols Blood Plasma Derivatives Introduction
11.1.4 Grifols Revenue in Blood Plasma Derivatives Business (2016-2021)
11.1.5 Grifols Recent Development
11.2 SK Plasma
11.2.1 SK Plasma Company Details
11.2.2 SK Plasma Business Overview
11.2.3 SK Plasma Blood Plasma Derivatives Introduction
11.2.4 SK Plasma Revenue in Blood Plasma Derivatives Business (2016-2021)
11.2.5 SK Plasma Recent Development
11.3 Fusion Health Care
11.3.1 Fusion Health Care Company Details
11.3.2 Fusion Health Care Business Overview
11.3.3 Fusion Health Care Blood Plasma Derivatives Introduction
11.3.4 Fusion Health Care Revenue in Blood Plasma Derivatives Business (2016-2021)
11.3.5 Fusion Health Care Recent Development
11.4 Biotest AG
11.4.1 Biotest AG Company Details
11.4.2 Biotest AG Business Overview
11.4.3 Biotest AG Blood Plasma Derivatives Introduction
11.4.4 Biotest AG Revenue in Blood Plasma Derivatives Business (2016-2021)
11.4.5 Biotest AG Recent Development
11.5 Green Cross Corporation
11.5.1 Green Cross Corporation Company Details
11.5.2 Green Cross Corporation Business Overview
11.5.3 Green Cross Corporation Blood Plasma Derivatives Introduction
11.5.4 Green Cross Corporation Revenue in Blood Plasma Derivatives Business (2016-2021)
11.5.5 Green Cross Corporation Recent Development
11.6 Baxter International
11.6.1 Baxter International Company Details
11.6.2 Baxter International Business Overview
11.6.3 Baxter International Blood Plasma Derivatives Introduction
11.6.4 Baxter International Revenue in Blood Plasma Derivatives Business (2016-2021)
11.6.5 Baxter International Recent Development
11.7 LFB
11.7.1 LFB Company Details
11.7.2 LFB Business Overview
11.7.3 LFB Blood Plasma Derivatives Introduction
11.7.4 LFB Revenue in Blood Plasma Derivatives Business (2016-2021)
11.7.5 LFB Recent Development
11.8 Octapharma AG
11.8.1 Octapharma AG Company Details
11.8.2 Octapharma AG Business Overview
11.8.3 Octapharma AG Blood Plasma Derivatives Introduction
11.8.4 Octapharma AG Revenue in Blood Plasma Derivatives Business (2016-2021)
11.8.5 Octapharma AG Recent Development
11.9 CSL Limited
11.9.1 CSL Limited Company Details
11.9.2 CSL Limited Business Overview
11.9.3 CSL Limited Blood Plasma Derivatives Introduction
11.9.4 CSL Limited Revenue in Blood Plasma Derivatives Business (2016-2021)
11.9.5 CSL Limited Recent Development
11.10 Takeda
11.10.1 Takeda Company Details
11.10.2 Takeda Business Overview
11.10.3 Takeda Blood Plasma Derivatives Introduction
11.10.4 Takeda Revenue in Blood Plasma Derivatives Business (2016-2021)
11.10.5 Takeda Recent Development
11.11 China Biologic Products
11.11.1 China Biologic Products Company Details
11.11.2 China Biologic Products Business Overview
11.11.3 China Biologic Products Blood Plasma Derivatives Introduction
11.11.4 China Biologic Products Revenue in Blood Plasma Derivatives Business (2016-2021)
11.11.5 China Biologic Products Recent Development
11.12 Kedrion Biopharma
11.12.1 Kedrion Biopharma Company Details
11.12.2 Kedrion Biopharma Business Overview
11.12.3 Kedrion Biopharma Blood Plasma Derivatives Introduction
11.12.4 Kedrion Biopharma Revenue in Blood Plasma Derivatives Business (2016-2021)
11.12.5 Kedrion Biopharma Recent Development
11.13 BDI Pharma
11.13.1 BDI Pharma Company Details
11.13.2 BDI Pharma Business Overview
11.13.3 BDI Pharma Blood Plasma Derivatives Introduction
11.13.4 BDI Pharma Revenue in Blood Plasma Derivatives Business (2016-2021)
11.13.5 BDI Pharma Recent Development
11.14 Bayer AG
11.14.1 Bayer AG Company Details
11.14.2 Bayer AG Business Overview
11.14.3 Bayer AG Blood Plasma Derivatives Introduction
11.14.4 Bayer AG Revenue in Blood Plasma Derivatives Business (2016-2021)
11.14.5 Bayer AG Recent Development
11.15 Hualan Biological Engineering
11.15.1 Hualan Biological Engineering Company Details
11.15.2 Hualan Biological Engineering Business Overview
11.15.3 Hualan Biological Engineering Blood Plasma Derivatives Introduction
11.15.4 Hualan Biological Engineering Revenue in Blood Plasma Derivatives Business (2016-2021)
11.15.5 Hualan Biological Engineering Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Blood Plasma Derivatives Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Albumin
Table 3. Key Players of Factor VIII
Table 4. Key Players of Factor IX
Table 5. Key Players of Immunoglobulin
Table 6. Key Players of Hyperimmune Globulin
Table 7. Key Players of Others
Table 8. Global Blood Plasma Derivatives Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Blood Plasma Derivatives Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Blood Plasma Derivatives Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Blood Plasma Derivatives Market Share by Regions (2016-2021)
Table 12. Global Blood Plasma Derivatives Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Blood Plasma Derivatives Market Share by Regions (2022-2027)
Table 14. Blood Plasma Derivatives Market Trends
Table 15. Blood Plasma Derivatives Market Drivers
Table 16. Blood Plasma Derivatives Market Challenges
Table 17. Blood Plasma Derivatives Market Restraints
Table 18. Global Blood Plasma Derivatives Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Blood Plasma Derivatives Market Share by Players (2016-2021)
Table 20. Global Top Blood Plasma Derivatives Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Blood Plasma Derivatives as of 2020)
Table 21. Ranking of Global Top Blood Plasma Derivatives Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Blood Plasma Derivatives Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Blood Plasma Derivatives Product Solution and Service
Table 25. Date of Enter into Blood Plasma Derivatives Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Blood Plasma Derivatives Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Blood Plasma Derivatives Revenue Market Share by Type (2016-2021)
Table 29. Global Blood Plasma Derivatives Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Blood Plasma Derivatives Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Blood Plasma Derivatives Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Blood Plasma Derivatives Revenue Market Share by Application (2016-2021)
Table 33. Global Blood Plasma Derivatives Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Blood Plasma Derivatives Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Blood Plasma Derivatives Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Blood Plasma Derivatives Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Blood Plasma Derivatives Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Blood Plasma Derivatives Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Blood Plasma Derivatives Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Blood Plasma Derivatives Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Blood Plasma Derivatives Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Blood Plasma Derivatives Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Blood Plasma Derivatives Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Blood Plasma Derivatives Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Blood Plasma Derivatives Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Blood Plasma Derivatives Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Blood Plasma Derivatives Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Blood Plasma Derivatives Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Blood Plasma Derivatives Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Blood Plasma Derivatives Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Blood Plasma Derivatives Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Blood Plasma Derivatives Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Blood Plasma Derivatives Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Blood Plasma Derivatives Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Blood Plasma Derivatives Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Blood Plasma Derivatives Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Blood Plasma Derivatives Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Blood Plasma Derivatives Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Blood Plasma Derivatives Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Blood Plasma Derivatives Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Blood Plasma Derivatives Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Blood Plasma Derivatives Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Blood Plasma Derivatives Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Blood Plasma Derivatives Market Size by Country (2022-2027) & (US$ Million)
Table 65. Grifols Company Details
Table 66. Grifols Business Overview
Table 67. Grifols Blood Plasma Derivatives Product
Table 68. Grifols Revenue in Blood Plasma Derivatives Business (2016-2021) & (US$ Million)
Table 69. Grifols Recent Development
Table 70. SK Plasma Company Details
Table 71. SK Plasma Business Overview
Table 72. SK Plasma Blood Plasma Derivatives Product
Table 73. SK Plasma Revenue in Blood Plasma Derivatives Business (2016-2021) & (US$ Million)
Table 74. SK Plasma Recent Development
Table 75. Fusion Health Care Company Details
Table 76. Fusion Health Care Business Overview
Table 77. Fusion Health Care Blood Plasma Derivatives Product
Table 78. Fusion Health Care Revenue in Blood Plasma Derivatives Business (2016-2021) & (US$ Million)
Table 79. Fusion Health Care Recent Development
Table 80. Biotest AG Company Details
Table 81. Biotest AG Business Overview
Table 82. Biotest AG Blood Plasma Derivatives Product
Table 83. Biotest AG Revenue in Blood Plasma Derivatives Business (2016-2021) & (US$ Million)
Table 84. Biotest AG Recent Development
Table 85. Green Cross Corporation Company Details
Table 86. Green Cross Corporation Business Overview
Table 87. Green Cross Corporation Blood Plasma Derivatives Product
Table 88. Green Cross Corporation Revenue in Blood Plasma Derivatives Business (2016-2021) & (US$ Million)
Table 89. Green Cross Corporation Recent Development
Table 90. Baxter International Company Details
Table 91. Baxter International Business Overview
Table 92. Baxter International Blood Plasma Derivatives Product
Table 93. Baxter International Revenue in Blood Plasma Derivatives Business (2016-2021) & (US$ Million)
Table 94. Baxter International Recent Development
Table 95. LFB Company Details
Table 96. LFB Business Overview
Table 97. LFB Blood Plasma Derivatives Product
Table 98. LFB Revenue in Blood Plasma Derivatives Business (2016-2021) & (US$ Million)
Table 99. LFB Recent Development
Table 100. Octapharma AG Company Details
Table 101. Octapharma AG Business Overview
Table 102. Octapharma AG Revenue in Blood Plasma Derivatives Business (2016-2021) & (US$ Million)
Table 103. Octapharma AG Recent Development
Table 104. CSL Limited Company Details
Table 105. CSL Limited Business Overview
Table 106. CSL Limited Blood Plasma Derivatives Product
Table 107. CSL Limited Revenue in Blood Plasma Derivatives Business (2016-2021) & (US$ Million)
Table 108. CSL Limited Recent Development
Table 109. Takeda Company Details
Table 110. Takeda Business Overview
Table 111. Takeda Blood Plasma Derivatives Product
Table 112. Takeda Revenue in Blood Plasma Derivatives Business (2016-2021) & (US$ Million)
Table 113. Takeda Recent Development
Table 114. China Biologic Products Company Details
Table 115. China Biologic Products Business Overview
Table 116. China Biologic Products Blood Plasma Derivatives Product
Table 117. China Biologic Products Revenue in Blood Plasma Derivatives Business (2016-2021) & (US$ Million)
Table 118. China Biologic Products Recent Development
Table 119. Kedrion Biopharma Company Details
Table 120. Kedrion Biopharma Business Overview
Table 121. Kedrion Biopharma Blood Plasma Derivatives Product
Table 122. Kedrion Biopharma Revenue in Blood Plasma Derivatives Business (2016-2021) & (US$ Million)
Table 123. Kedrion Biopharma Recent Development
Table 124. BDI Pharma Company Details
Table 125. BDI Pharma Business Overview
Table 126. BDI Pharma Blood Plasma Derivatives Product
Table 127. BDI Pharma Revenue in Blood Plasma Derivatives Business (2016-2021) & (US$ Million)
Table 128. BDI Pharma Recent Development
Table 129. Bayer AG Company Details
Table 130. Bayer AG Business Overview
Table 131. Bayer AG Blood Plasma Derivatives Product
Table 132. Bayer AG Revenue in Blood Plasma Derivatives Business (2016-2021) & (US$ Million)
Table 133. Bayer AG Recent Development
Table 134. Hualan Biological Engineering Company Details
Table 135. Hualan Biological Engineering Business Overview
Table 136. Hualan Biological Engineering Blood Plasma Derivatives Product
Table 137. Hualan Biological Engineering Revenue in Blood Plasma Derivatives Business (2016-2021) & (US$ Million)
Table 138. Hualan Biological Engineering Recent Development
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Blood Plasma Derivatives Market Share by Type: 2020 VS 2027
Figure 2. Albumin Features
Figure 3. Factor VIII Features
Figure 4. Factor IX Features
Figure 5. Immunoglobulin Features
Figure 6. Hyperimmune Globulin Features
Figure 7. Others Features
Figure 8. Global Blood Plasma Derivatives Market Share by Application: 2020 VS 2027
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Other End Users Case Studies
Figure 12. Blood Plasma Derivatives Report Years Considered
Figure 13. Global Blood Plasma Derivatives Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Blood Plasma Derivatives Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Blood Plasma Derivatives Market Share by Regions: 2020 VS 2027
Figure 16. Global Blood Plasma Derivatives Market Share by Regions (2022-2027)
Figure 17. Global Blood Plasma Derivatives Market Share by Players in 2020
Figure 18. Global Top Blood Plasma Derivatives Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Blood Plasma Derivatives as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Blood Plasma Derivatives Revenue in 2020
Figure 20. Global Blood Plasma Derivatives Revenue Market Share by Type (2016-2021)
Figure 21. Global Blood Plasma Derivatives Revenue Market Share by Type (2022-2027)
Figure 22. North America Blood Plasma Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Blood Plasma Derivatives Market Share by Type (2016-2027)
Figure 24. North America Blood Plasma Derivatives Market Share by Application (2016-2027)
Figure 25. North America Blood Plasma Derivatives Market Share by Country (2016-2027)
Figure 26. United States Blood Plasma Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Blood Plasma Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Blood Plasma Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Blood Plasma Derivatives Market Share by Type (2016-2027)
Figure 30. Europe Blood Plasma Derivatives Market Share by Application (2016-2027)
Figure 31. Europe Blood Plasma Derivatives Market Share by Country (2016-2027)
Figure 32. Germany Blood Plasma Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Blood Plasma Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Blood Plasma Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Blood Plasma Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Blood Plasma Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Blood Plasma Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Blood Plasma Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Blood Plasma Derivatives Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Blood Plasma Derivatives Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Blood Plasma Derivatives Market Share by Region (2016-2027)
Figure 42. China Blood Plasma Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Blood Plasma Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Blood Plasma Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Blood Plasma Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Blood Plasma Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Blood Plasma Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Blood Plasma Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Blood Plasma Derivatives Market Share by Type (2016-2027)
Figure 50. Latin America Blood Plasma Derivatives Market Share by Application (2016-2027)
Figure 51. Latin America Blood Plasma Derivatives Market Share by Country (2016-2027)
Figure 52. Mexico Blood Plasma Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Blood Plasma Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Blood Plasma Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Blood Plasma Derivatives Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Blood Plasma Derivatives Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Blood Plasma Derivatives Market Share by Country (2016-2027)
Figure 58. Turkey Blood Plasma Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Blood Plasma Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Blood Plasma Derivatives Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Grifols Revenue Growth Rate in Blood Plasma Derivatives Business (2016-2021)
Figure 62. SK Plasma Revenue Growth Rate in Blood Plasma Derivatives Business (2016-2021)
Figure 63. Fusion Health Care Revenue Growth Rate in Blood Plasma Derivatives Business (2016-2021)
Figure 64. Biotest AG Revenue Growth Rate in Blood Plasma Derivatives Business (2016-2021)
Figure 65. Green Cross Corporation Revenue Growth Rate in Blood Plasma Derivatives Business (2016-2021)
Figure 66. Baxter International Revenue Growth Rate in Blood Plasma Derivatives Business (2016-2021)
Figure 67. LFB Revenue Growth Rate in Blood Plasma Derivatives Business (2016-2021)
Figure 68. Octapharma AG Revenue Growth Rate in Blood Plasma Derivatives Business (2016-2021)
Figure 69. CSL Limited Revenue Growth Rate in Blood Plasma Derivatives Business (2016-2021)
Figure 70. Takeda Revenue Growth Rate in Blood Plasma Derivatives Business (2016-2021)
Figure 71. China Biologic Products Revenue Growth Rate in Blood Plasma Derivatives Business (2016-2021)
Figure 72. Kedrion Biopharma Revenue Growth Rate in Blood Plasma Derivatives Business (2016-2021)
Figure 73. BDI Pharma Revenue Growth Rate in Blood Plasma Derivatives Business (2016-2021)
Figure 74. Bayer AG Revenue Growth Rate in Blood Plasma Derivatives Business (2016-2021)
Figure 75. Hualan Biological Engineering Revenue Growth Rate in Blood Plasma Derivatives Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
世界の動物血漿＆誘導体市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Animal Blood Plasma and Derivatives Market The global Animal Blood Plasma and Derivatives market size is projected to reach US$ 1343.1 million by 2027, from US$ 981.1 million in 2020, at a CAGR of 4.5% during 2021-2027. With industry-standard accuracy in analysis…- 動物血漿＆誘導体のグローバル市場調査 2019年 The global Animal Blood Plasma and Derivatives market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Animal Blood Plasma and Derivatives volume and value at global level, regional level and company level.…
- ヒト血液凝固因子VIIIのグローバル市場2021 Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A. North America is the largest consumption market of Human Coagulation Factor VIII, with sal…
- 世界の血漿由来人血清アルブミン検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Plasma-derived Human Serum Albumin Test Market The global Plasma-derived Human Serum Albumin Test market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis…
- 血漿分画のグローバル市場調査 2019年 The global Blood Plasma Fractionation market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Blood Plasma Fractionation volume and value at global level, regional level and company level. From a global per…